RxDoctor Payments DataLook up a doctor →

Karamali Bandealy

Rheumatology · Kissimmee, FLNPI 1982686135

Payments from drug & device makers

$686,768in general payments, 2019–2025

Across 621 payments — averaging $1105.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sun Pharmaceutical Industries Inc.$426K
  • Eli Lilly$143K
  • E.r. Squibb & Sons, L.L.C.$91K
  • Boehringer Ingelheim$12K
  • Navidea Biopharmaceuticals, Inc.$7K
  • Boehringer Ingelheim France S.a.s.$3K
  • plus $6K from 20 others
$105in research payments, 2019–2025

Across 1 payment — averaging $104.58 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$105

What the payments were for

  • Food & beverage$6,662100%
  • Education$180%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$686,768 in reported general payments places this provider in the 90th percentile of 453 rheumatology providers in Florida.

See all rheumatology providers in Florida

Other rheumatology in Kissimmee

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →